Christa Nicholas

Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC.

Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA.

Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA.

Gauss Surgical, Inc. engages in mobile health operation which specializes in blood and hemoglobin loss monitoring during surgery. Its services include research and development, publications, clinical performance, feature extraction technology, rapid integration with surgical workflow, and inoperative mobile platform. The company was founded by Siddarth Satish in 2011 and is headquartered in Los Altos, CA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Part of 1105 Media, Inc., Fawcette Technical Publications, Inc. publishes magazines and produces websites for the Information Technology community. The company is based in San Mateo, CA. Fawcette Technical Publications was acquired by 1105 Media, Inc. on January 02, 2007.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Norwest Venture Partners is a venture capital division of Norwest Partners founded in 1961. The firm is headquartered in Palo Alto, California with additional offices in Mumbai and Herzliya.

Apposite Capital LLP (Apposite Capital) is a private equity arm of Mizuho Financial Group, Inc. founded in 2016 by David Porter. The firm is headquartered in London, United Kingdom.

Cianna Medical, Inc. manufactures and marketing equipment for the treatment of early-stage breast cancer in women. The firm’s products include SAVI, a breast brachytherapy applicator used for the delivery of radiation after lumpectomy surgery; and SAVI SCOUT, a surgical guidance system that uses real-time audible and visual indicators to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures. The company was founded in 2007 and is headquartered in Aliso Viejo, CA.

Malaysian Life Sciences Capital Fund Management Co Ltd (MLSCFM) is a venture capital firm founded in 2006. The firm is headquartered in Kuala Lumpur, Malaysia.

DCVC Management Co LLC (DCVC) is a venture capital firm founded in 2011 by Zachary Bogue and Matthew Ocko. The firm is headquartered in San Francisco, California.

Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden.

Jump Capital LLC (Jump Capital) is a venture capital firm founded in 2012 by Mike B. McMahon and Sach Chitnis. The firm is headquartered in Chicago.

Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.

MDLIVE, Inc. operates as a telehealth provider of online and on-demand healthcare delivery services and software. Its cloud-based virtual medical office software platform enables patients, medical professionals, and plan administrators to collaborate through voice, video, email, and mobile devices; and allows payers and providers to collect and share clinical data from patient medical records, lab results, and in-home biometric devices for real-time risk assessments, wellness advice, diagnosis, and treatment. The company was founded by Randy Parker and Steven Victor Gurland in 2009 and is headquartered in Sunrise, FL.

Pieces Technologies, Inc. develops healthcare software solutions. Its products include pieces IRIS and pieces decision support. The company was founded by Ruben Amarasingham in 2007 and is headquartered in Dallas, TX.

OSF Ventures (OSF Ventures) is a venture capital subsidiary of OSF Healthcare System founded in 2016. The firm is headquartered in Illinois, Chicago.

Level Ex, Inc. engages in the provision of medical video games for physicians. It offers Cardio Ex, Pulm Ex, Gastro Ex, and Airway Ex games. The company was founded by Sam Z. Glassenberg in 2015 and is headquartered in Chicago, IL.

HealthBridge Financial, Inc. provides health insurance services. It offers design, underwriting and servicing of credit solutions. The company is headquartered in Grand Rapids, MI.

Inflammatix, Inc. operates molecular diagnostics company which develops rapid tests that read the immune system. The firm specializes in molecular diagnostics, biotechnology, computational immunology, in-vitro diagnostics, personalized medicine and bioinformatics. The company was founded by Purvesh Khatri, Jonathan Romanowsky and Timothy Sweeney and is headquartered in Burlingame, CA.

Corsair Pharma, Inc. is a development stage biotechnology company. It focuses on the development of novel prodrugs of treprostinil to treat patients with pulmonary arterial hypertension using a once-daily transdermal patch. The company is headquartered in South San Francisco, CA.

Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA.

MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN.

TherOptix, Inc. develops and manufactures drug-eluting contact lens. The company is headquartered in San Francisco, CA.

Allievex Corp. operates as a biotechnology company. It develops therapies for the treatment of rare pediatric neurodegenerative diseases. The company was founded by Thomas P. Mathers and Eric H. Zanelli and is headquartered in Marblehead, MA.

Health Scholars, Inc. engages as a cloud-based, VR-ready training platform for the management, delivery, and analysis of clinical training. Its solutions include virtual reality training, and simulation management. The company was founded by Brian Gillett in 2017 and is headquartered in Westminster, CO.

KeifeRx LLC is a clinical-stage biopharmaceutical company that develops novel and optimized tyrosine kinase inhibitors (TKIs) for the treatment of neurodegenerative and immune diseases. KeifeRx is based in McLean, VA, and was founded in 2019 by Charbel Moussa and Fernando Pagan. The company's clinical pipeline is led by Nilotinib BE, an optimized, lower dose formulation of Nilotinib, which is currently in a multicenter phase 3 clinical trial for early Alzheimer's disease. KeifeRx's TKI portfolio includes an optimized oral dose of Bosutinib and Gutinib, which are undergoing clinical trials in Lewy body dementia and optimizing and IND enabling studies, respectively. The company's technologies are designed to treat neurodegenerative diseases and an array of inflammatory diseases where there are significant unmet clinical needs and limited therapeutic options. Chris Hoyt has been the CEO of the company since 2021.

Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation.

Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation.

Riverine Ventures is a venture capital firm founded in 2022 by Garrett Vygantas. The firm is headquartered in Sausalito, California.